Nucana Plc Stock Today
| NCNA Stock | USD 3.84 0.16 4.00% |
Performance0 of 100
| Odds Of DistressLess than 50
|
NuCana PLC is trading at 3.84 as of the 24th of April 2024, a -4 percent decrease since the beginning of the trading day. The stock's open price was 4.0. NuCana PLC has 50 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Equity ratings for NuCana PLC are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 28th of September 2017 | Category Healthcare | Classification Health Care |
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. NuCana plc was incorporated in 1997 and is headquartered in Edinburgh, the United Kingdom. Nucana Plc is traded on NASDAQ Exchange in the United States. The company has 2.11 M outstanding shares of which 164.89 K shares are now shorted by private and institutional investors with about 0.04 trading days to cover. More on NuCana PLC
Moving against NuCana Stock
| 0.84 | ACB | Aurora Cannabis Trending | PairCorr |
| 0.73 | ELYM | Eliem Therapeutics | PairCorr |
| 0.73 | CGC | Canopy Growth Corp Trending | PairCorr |
| 0.59 | XFOR | X4 Pharmaceuticals Earnings Call Next Week | PairCorr |
| 0.47 | NRSNW | NeuroSense Therapeutics | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Financial Report 15th of May 2024
NuCana Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. NuCana PLC's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding NuCana PLC or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO, Founder, Director | Hugh Griffith | |||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Cancer Fighters (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Cancer Fighters, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering NuCana PLC report their recommendations after researching NuCana PLC's financial statements, talking to executives and customers, or listening in on NuCana PLC's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering NuCana PLC. The NuCana consensus assessment is calculated by taking the average forecast from all of the analysts covering NuCana PLC. | ||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the measurements of operating efficiency obtained from NuCana PLC's historical financial statements, NuCana PLC is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of NuCana PLC is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||
NuCana PLC's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to NuCana PLC's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand NuCana PLC's financial leverage. It provides some insight into what part of NuCana PLC's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
NuCana PLC (NCNA) is traded on NASDAQ Exchange in USA. It is located in 3 Lochside Way, Edinburgh, United Kingdom, EH12 9DT and employs 25 people. NuCana PLC is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.46 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NuCana PLC's market, we take the total number of its shares issued and multiply it by NuCana PLC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. NuCana PLC conducts business under Biotechnology sector and is part of Health Care industry. The entity has 2.11 M outstanding shares of which 164.89 K shares are now shorted by private and institutional investors with about 0.04 trading days to cover.
NuCana PLC currently holds about 46.53 M in cash with (26.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.9.
Check NuCana PLC Probability Of Bankruptcy
Ownership AllocationAround 71.0 % of NuCana PLC outstanding shares are held by general public with 0.564 percent owned by insiders and only 28.43 (percent) by institutions.
Check NuCana Ownership Details
NuCana Stock Price Odds Analysis
What are NuCana PLC's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of NuCana PLC jumping above the current price in 90 days from now is about 99.0%. The NuCana PLC probability density function shows the probability of NuCana PLC stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.3534. This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, NuCana PLC will likely underperform. Additionally, nuCana PLC has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of NuCana PLC to move above the current price in 90 days from now is about 99.0 (This NuCana PLC probability density function shows the probability of NuCana Stock to fall within a particular range of prices over 90 days) .
NuCana Stock Institutional Holders
Institutional Holdings refers to the ownership stake in NuCana PLC that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of NuCana PLC's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing NuCana PLC's value.| Instituion | Recorded On | Shares | |
| Glass Jacobson Investment Advisors Llc | 2023-12-31 | 15 K | |
| Millennium Management Llc | 2023-12-31 | 12.8 K | |
| Traynor Capital Management, Inc | 2023-12-31 | 11 K | |
| Turtle Creek Wealth Advisors Llc | 2023-12-31 | 5.9 K | |
| Allsquare Wealth Management Llc | 2023-12-31 | 5.1 K | |
| Newbridge Financial Services Group, Inc. | 2023-12-31 | 1.7 K | |
| Advisor Group Holdings, Inc. | 2023-12-31 | 1.7 K | |
| Activest Wealth Management | 2023-12-31 | 836 | |
| Ubs Group Ag | 2023-12-31 | 350 | |
| Sofinnova Ventures | 2023-12-31 | 4.7 M | |
| Baillie Gifford & Co Limited. | 2023-12-31 | 3.7 M |
NuCana PLC Historical Income Statement
NuCana PLC Income Statement is one of the three primary financial statements used for reporting NuCana's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of NuCana PLC revenue and expense. NuCana PLC Income Statement primarily focuses on the company's revenues and expenses during a particular period.
The current year's Reconciled Depreciation is expected to grow to about 694.9 K, whereas Interest Expense is forecasted to decline to about 1 M. View More FundamentalsNuCana Stock Against Markets
Picking the right benchmark for NuCana PLC stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in NuCana PLC stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for NuCana PLC is critical whether you are bullish or bearish towards NuCana PLC at a given time. Please also check how NuCana PLC's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in NuCana PLC without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
NuCana PLC Corporate Management
Elected by the shareholders, the NuCana PLC's board of directors comprises two types of representatives: NuCana PLC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NuCana. The board's role is to monitor NuCana PLC's management team and ensure that shareholders' interests are well served. NuCana PLC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NuCana PLC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Harrison | Head Medicine | Profile | |
| MD FACOG | Chief Officer | Profile | |
| Donald Munoz | Chief Officer | Profile | |
| Theresa Bruce | Senior Operations | Profile |
How to buy NuCana Stock?
Before investing in NuCana PLC, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in NuCana PLC. To buy NuCana PLC stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of NuCana PLC. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase NuCana PLC stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located NuCana PLC stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased NuCana PLC stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as NuCana PLC, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy NuCana Stock please use our How to Invest in NuCana PLC guide.
Already Invested in NuCana PLC?
The danger of trading NuCana PLC is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of NuCana PLC is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than NuCana PLC. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile NuCana PLC is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether NuCana PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NuCana PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nucana Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nucana Plc Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NuCana PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade NuCana Stock refer to our How to Trade NuCana Stock guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for NuCana Stock analysis
When running NuCana PLC's price analysis, check to measure NuCana PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NuCana PLC is operating at the current time. Most of NuCana PLC's value examination focuses on studying past and present price action to predict the probability of NuCana PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NuCana PLC's price. Additionally, you may evaluate how the addition of NuCana PLC to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Stocks Directory Find actively traded stocks across global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is NuCana PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NuCana PLC. If investors know NuCana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NuCana PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (16.39) | Return On Assets (0.45) | Return On Equity (1.04) |
The market value of NuCana PLC is measured differently than its book value, which is the value of NuCana that is recorded on the company's balance sheet. Investors also form their own opinion of NuCana PLC's value that differs from its market value or its book value, called intrinsic value, which is NuCana PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NuCana PLC's market value can be influenced by many factors that don't directly affect NuCana PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NuCana PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if NuCana PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NuCana PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.